Florida Sues Pfizer and CEO Over Alleged Vaccine Risk Deception

The 49-page complaint was filed on Oct. 1, 2026, in Florida’s 19th Judicial Circuit Court in St. Lucie County, under the state’s Deceptive and Unfair Trade Practices Act.
Florida’s complaint says Pfizer generated about $80 billion in COVID-19 vaccine sales, spent roughly $10 billion on advertising from 2020 to 2023, and raised the per-dose price in 2023 from about $30 to between $110 and $130.
The lawsuit notes that Pfizer said it was aware of myocarditis reports but that no causal link had been established; the CDC later said in 2023 that a causal link existed.
Pfizer’s current website says its data show increased risks of myocarditis and pericarditis, particularly during the first week after vaccination. Its vaccine label also says there are no available data to inform risks of major birth defects or miscarriage for use in pregnant women before 24 weeks of gestation.
Florida's Attorney General James Uthmeier sued Pfizer and CEO Albert Bourla on October 1, 2026, alleging the company deceived consumers about COVID-19 vaccine safety and effectiveness Economic Times. The 49-page complaint claims Pfizer failed to disclose risks like myocarditis and pericarditis in young people, overstated the vaccine's ability to stop transmission, and used unfair marketing practices The Epoch Times. Pfizer disputes the allegations, saying its statements were accurate and science-based.
Florida alleges Pfizer generated roughly $80 billion in vaccine sales and spent about $10 billion on advertising between 2020 and 2023 The New American. The state is seeking financial penalties and recovery of profits under Florida's Deceptive and Unfair Trade Practices Act.
The complaint says Pfizer was aware of myocarditis reports but claimed no causal link existed Economic Times. However, the CDC concluded in 2023 that a causal link between the vaccine and myocarditis did exist, especially in young people The Deep Dive. This shift contradicts Pfizer's earlier public statements, the lawsuit argues.
Today, Pfizer's website acknowledges increased risks of myocarditis and pericarditis, particularly in the first week after vaccination The Epoch Times. The company's vaccine label also states there are no available data on risks of birth defects or miscarriage for pregnant women before 24 weeks of gestation The Epoch Times.
Pfizer raised the per-dose price from about $30 to between $110 and $130 in 2023 The New American. During the same period, the company spent roughly $10 billion on advertising from 2020 to 2023 The New American. Florida argues these moves, combined with alleged safety misstatements, violated consumer protection laws.
Pfizer maintains that its statements about the vaccine were accurate and science-based The Epoch Times. The company has said its data do not show that abnormalities observed in animal testing were caused by the vaccine Economic Times. Pfizer did not immediately comment on the specific allegations in Florida's lawsuit.
The lawsuit was filed in Florida's 19th Judicial Circuit Court in St. Lucie County The New American. The case will now move through the Florida court system, where both sides will present evidence and arguments. The outcome could set a precedent for how states handle vaccine-related marketing claims.
Publishers
16
Articles
69
Reach
85